http://orcid.org/0000-0003-2019-6189
Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Susanne Lilleskare, Marta Vorland, Anh Khoi Vo, Aasne K. Aarsand & Håkon Reikvam. (2023) Frequency of JAK2V617F, MPL and CALR driver mutations and associated clinical characteristics in a Norwegian patient cohort with myeloproliferative neoplasms. Scandinavian Journal of Clinical and Laboratory Investigation 83:1, pages 3-7.
Read now
Read now
Articles from other publishers (4)
Bestoon Muhammad Saeed, Hisham Arif Getta, Najmaddin Khoshnaw, Goran Abdulqader, Aveen M. Raouf Abdulqader & Ali Ibrahim Mohammed. (2021)
Prevalence of
JAK2 V617F, CALR
, and
MPL W515L
Gene Mutations in Patients with Essential Thrombocythemia in Kurdistan Region of Iraq
. The Korean Journal of Clinical Laboratory Science 53:1, pages 41-48.
Crossref
Crossref
Ayşe UYSAL, Şule ALTINER, Said ÇELİK, Serhat UYSAL & Alper Han ÇEBİ. (2020) Genetic analysis of BCR-ABL negative chronic myeloproliferative diseases at initial diagnosis and their clinical effectsBCR-ABL negatif kronik myeloproliferatif hastalıkların tanı anındaki genetik analizleri ve bunların klinik etkileri. Cukurova Medical Journal 45:3, pages 933-939.
Crossref
Crossref
Tanja Belcic Mikic, Tadej Pajic & Matjaz Sever. (2019) CALR mutations in a cohort of JAK2 V617F negative patients with suspected myeloproliferative neoplasms. Scientific Reports 9:1.
Crossref
Crossref
Tao Lang, Yuling Nie, Zengsheng Wang, Qin Huang, Li An, Yichun Wang, Guzailinuer Wufuer, Aziguli Maimaiti, Ling Fu, Yan Li, Xiaoyan Zhang, Aihemaitijiang Aisimutula, Xiaomin Wang, Lin Zhu, Hong Liu & Min Mao. (2018)
Correlation analysis between
JAK2
,
MPL
, and
CALR
mutations in patients with myeloproliferative neoplasms of Chinese Uygur and Han nationality and their clinical characteristics
. Journal of International Medical Research 46:11, pages 4650-4659.
Crossref
Crossref